GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » The Hydration Pharmaceuticals Co Ltd (ASX:HPC) » Definitions » EV-to-Revenue

The Hydration Pharmaceuticals Co (ASX:HPC) EV-to-Revenue : 0.41 (As of Jun. 24, 2024)


View and export this data going back to 2021. Start your Free Trial

What is The Hydration Pharmaceuticals Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, The Hydration Pharmaceuticals Co's enterprise value is A$6.13 Mil. The Hydration Pharmaceuticals Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$14.99 Mil. Therefore, The Hydration Pharmaceuticals Co's EV-to-Revenue for today is 0.41.

The historical rank and industry rank for The Hydration Pharmaceuticals Co's EV-to-Revenue or its related term are showing as below:

ASX:HPC' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.95   Med: 0.4   Max: 1.22
Current: 0.41

During the past 3 years, the highest EV-to-Revenue of The Hydration Pharmaceuticals Co was 1.22. The lowest was -0.95. And the median was 0.40.

ASX:HPC's EV-to-Revenue is ranked better than
61.36% of 308 companies
in the Retail - Defensive industry
Industry Median: 0.53 vs ASX:HPC: 0.41

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-24), The Hydration Pharmaceuticals Co's stock price is A$0.01. The Hydration Pharmaceuticals Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.08. Therefore, The Hydration Pharmaceuticals Co's PS Ratio for today is 0.13.


The Hydration Pharmaceuticals Co EV-to-Revenue Historical Data

The historical data trend for The Hydration Pharmaceuticals Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Hydration Pharmaceuticals Co EV-to-Revenue Chart

The Hydration Pharmaceuticals Co Annual Data
Trend Dec21 Dec22 Dec23
EV-to-Revenue
3.90 0.99 0.63

The Hydration Pharmaceuticals Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue - - 0.99 - 0.63

Competitive Comparison of The Hydration Pharmaceuticals Co's EV-to-Revenue

For the Food Distribution subindustry, The Hydration Pharmaceuticals Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Hydration Pharmaceuticals Co's EV-to-Revenue Distribution in the Retail - Defensive Industry

For the Retail - Defensive industry and Consumer Defensive sector, The Hydration Pharmaceuticals Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where The Hydration Pharmaceuticals Co's EV-to-Revenue falls into.



The Hydration Pharmaceuticals Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

The Hydration Pharmaceuticals Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=6.128/14.987
=0.41

The Hydration Pharmaceuticals Co's current Enterprise Value is A$6.13 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. The Hydration Pharmaceuticals Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$14.99 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Hydration Pharmaceuticals Co  (ASX:HPC) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

The Hydration Pharmaceuticals Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.01/0.075
=0.13

The Hydration Pharmaceuticals Co's share price for today is A$0.01.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was A$0.08.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Hydration Pharmaceuticals Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of The Hydration Pharmaceuticals Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


The Hydration Pharmaceuticals Co (ASX:HPC) Business Description

Traded in Other Exchanges
N/A
Address
6 Palmer Parade, Level 2, Cremorne, Melbourne, VIC, AUS, 3121
The Hydration Pharmaceuticals Co Ltd is engaged in the marketing and sale of liquid, tablet and powder hydration solution products into the North American markets of Canada and the United States. Some of its products include Hydration + Immune System Boost, Effervescent Electrolyte Tablets, Oral Rehydration Solution, and Immunity Booster Bundle.

The Hydration Pharmaceuticals Co (ASX:HPC) Headlines

No Headlines